In January, approximately 6,000 children in Uzbekistan contracted Hepatitis A

Since the start of 2024, 5,907 children have been diagnosed with Hepatitis A in Uzbekistan, as reported by the Information and Mass Communications Agency of Uzbekistan.

An increase in infection rates has been noted in several regions of Uzbekistan, including Andijan, Bukhara, Namangan, Surkhandarya, Samarkand, Fergana, and the Republic of Karakalpakstan, according to statistical data.

Vaccination against Hepatitis A prevents virus transmission in 94-98% of cases, with no serious complications reported post-vaccination. Certified vaccines ensure safety and quality, with WHO recommending a single dose without the need for revaccination.

Children aged 18 months to 14 years receive the Hepatitis A vaccine, providing immunity for up to 15 years.

Hepatitis A, a viral liver disease primarily affecting children, saw 365,167 children in Uzbekistan vaccinated against it in 2023.